Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic [0.03%]
新冠疫情期间低剂量利妥昔单抗治疗类风湿关节炎的六月评估研究
Yunus Durmaz,Ilker Ilhanli
Yunus Durmaz
Aim of the work: To evaluate the 6-month treatment responses to low dose rituximab (LDR) compared to standard dose rituximab (SDR) in rheumatoid arthritis (RA) patients whose treatments were disrupted due to the pandemic ...
Simultaneous occurrence of knee septic arthritis and coronavirus disease 2019 (COVID-19): A case report [0.03%]
膝关节化脓性关节炎和冠状病毒疾病2019（COVID-19）同时发生的一例报告
Mandana Khodashahi,Rozita Khodashahi,Zeinab Saremi
Mandana Khodashahi
Background: Coronavirus disease 2019 (COVID-19) pandemic is increasingly recognized as a serious, worldwide public health concern. Most of the patients with COVID-19 are asymptomatic or show mild symptoms. It is important...
Patient-reported outcome measure of the quality of life in Ugandans living with autoimmune rheumatic diseases [0.03%]
乌干达自身免疫性风湿病患者的生活质量评测
Felix Bongomin,Maria Sekimpi,Barbra Natukunda et al.
Felix Bongomin et al.
Aim of the work: To assess the patient reported outcome measure (PROM) of the quality of life (QoL) of patients with autoimmune rheumatic diseases (RDs) attending two tertiary care rheumatology clinics in Uganda. ...